TIAA CREF Investment Management’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $3.85M | Buy |
169,910
+2,539
| +2% | +$57.6K | ﹤0.01% | 1606 |
|
|
2018
Q4 | $4.28M | Buy |
167,371
+8,405
| +5% | +$215K | ﹤0.01% | 1474 |
|
|
2018
Q3 | $5.19M | Buy |
158,966
+34,495
| +28% | +$1.13M | ﹤0.01% | 1533 |
|
|
2018
Q2 | $2.82M | Sell |
124,471
-341
| -0.3% | -$7.73K | ﹤0.01% | 1984 |
|
|
2018
Q1 | $3.03M | Sell |
124,812
-1,037
| -0.8% | -$25.2K | ﹤0.01% | 1872 |
|
|
2017
Q4 | $3.51M | Sell |
125,849
-7,417
| -6% | -$207K | ﹤0.01% | 1823 |
|
|
2017
Q3 | $4.56M | Sell |
133,266
-20,892
| -14% | -$715K | ﹤0.01% | 1686 |
|
|
2017
Q2 | $6.14M | Buy |
154,158
+27,472
| +22% | +$1.09M | ﹤0.01% | 1462 |
|
|
2017
Q1 | $4.67M | Sell |
126,686
-8,815
| -7% | -$325K | ﹤0.01% | 1637 |
|
|
2016
Q4 | $4.32M | Buy |
135,501
+13,100
| +11% | +$418K | ﹤0.01% | 1703 |
|
|
2016
Q3 | $4.44K | Sell |
122,401
-2,518
| -2% | -$91 | ﹤0.01% | 1685 |
|
|
2016
Q2 | $2.83M | Buy |
124,919
+38,140
| +44% | +$865K | ﹤0.01% | 1918 |
|
|
2016
Q1 | $1.63M | Buy |
86,779
+5,375
| +7% | +$101K | ﹤0.01% | 2203 |
|
|
2015
Q4 | $1.33M | Sell |
81,404
-3,412
| -4% | -$55.9K | ﹤0.01% | 2405 |
|
|
2015
Q3 | $932K | Buy |
84,816
+1,369
| +2% | +$15K | ﹤0.01% | 2603 |
|
|
2015
Q2 | $1.09M | Sell |
83,447
-484
| -0.6% | -$6.3K | ﹤0.01% | 2652 |
|
|
2015
Q1 | $1.46M | Hold |
83,931
| – | – | ﹤0.01% | 2423 |
|
|
2014
Q4 | $1.25M | Sell |
83,931
-23,812
| -22% | -$355K | ﹤0.01% | 2533 |
|
|
2014
Q3 | $2.48M | Sell |
107,743
-11,635
| -10% | -$268K | ﹤0.01% | 2092 |
|
|
2014
Q2 | $3.81M | Buy |
+119,378
| New | +$3.81M | ﹤0.01% | 1871 |
|